Cambridge Investment Research Advisors
NUVA

Cambridge Investment Research Advisors’s NuVasive, Inc. NUVA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,675
Closed -$274K – 1994
2017
Q1 		$274K Buy
+3,675
New +$267K ﹤0.01% 1446

Other funds holding NUVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Cambridge Investment Research Advisors's NUVA Position: Q2 2017 in Review

Cambridge Investment Research Advisors sold out of NuVasive, Inc. (NUVA) in Q2 2017, closing a stake of 3,675 shares — an estimated $274K sold.

Cambridge Investment Research Advisors first reported a position in NUVA in Q1 2017 and held it in 1 quarter. The position peaked at $274K in Q1 2017. 298 funds tracked by Wall St. Rank hold NUVA as of Q2 2017.

  • Cambridge Investment Research Advisors reported no remaining NuVasive, Inc. position as of Q2 2017 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 3,675 NuVasive, Inc. shares in Q2 2017, an estimated $274K.
  • Cambridge Investment Research Advisors first reported a position in NuVasive, Inc. in Q1 2017 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's NuVasive, Inc. position peaked at $274K in Q1 2017.
  • 298 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2017.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2017, filed 8 Aug 2017.